Tag: Beta-carboline reversible MAO-A inhibitor

  • Harmaline

    Beta-carboline reversible MAO-A inhibitor

    A beta-carboline alkaloid from Peganum harmala and Banisteriopsis caapi; a reversible MAO-A inhibitor and component of ayahuasca.

    Abstract

    Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole; CAS 304-21-2; molecular formula C13H14N2O; molecular weight 214.27) is a beta-carboline alkaloid isolated from Peganum harmala (Syrian rue) and Banisteriopsis caapi (ayahuasca vine). The compound is a reversible MAO-A inhibitor (Ki approximately 5 microM at human MAO-A) with greater than 100-fold selectivity over MAO-B; this reversible MAO-A inhibition is central to the pharmacology of ayahuasca, where harmaline (and harmine) prevent intestinal breakdown of the DMT in the brew, allowing oral activity. Harmaline itself has serotonergic and tremorgenic effects in animals and mild psychoactive effects in humans. Plasma half-life is approximately 2 to 3 hours. Used as a reference reversible MAO-A inhibitor and as a research probe for beta-carboline pharmacology.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.